Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes. (Q54515468)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22527371

Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes. (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22527371

1 reference

based on heuristic

inferred from title

object named as

Jeong-Ah Kim

4

0 references

object named as

Eun Ju Son

2

0 references

object named as

Eun-Kyung Kim

5

0 references

author name string

Ji Hyun Youk

1

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22527371

Jin Chung

3

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22527371

language of work or name

0 references

publication date

17 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22527371

European Radiology

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22527371

22

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22527371

8

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22527371

1724-1734

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22527371

Clinicopathological features and treatment strategy for triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Preoperative assessment of prognostic factors in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Vascular characterisation of triple negative breast carcinomas using dynamic MRI.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Triple-Negative Breast Cancer: Clinical and Histological Correlations.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Triple-negative breast cancer: correlation between imaging and pathological findings

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Triple-negative breast cancer: what the radiologist needs to know

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Triple-negative breast cancer: MRI features in 29 patients

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Triple-negative breast cancer: correlation between MR imaging and pathologic findings

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Triple-negative breast cancer: present challenges and new perspectives

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its impl

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Triple-negative breast cancer: clinical features and patterns of recurrence

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC).

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Discordance in early breast cancer for tumour grade, estrogen receptor, progesteron receptors and human epidermal receptor-2 status between core needle biopsy and surgical excisional primary tumour

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Comparison of core needle biopsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR and HER2 status of breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Triple negative breast cancer: unmet medical needs

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Diffusion magnetic resonance imaging of the breast

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5-T.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

1 reference

https://api.crossref.org/works/10.1007%2FS00330-012-2425-2

21 January 2018

Understanding and treating triple-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of 3.0-and 1.5-tesla diffusion-weighted imaging in the visibility of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527371

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00330-012-2425-2

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22527371

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22527371

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54515468&oldid=2212497252"